LYKALABS Limited = RESULTS = FOR QTR ENDED DEC 2010 = LACK LUSTRE

Lyka Labs Limited

NSE Symbol       LYKALABS

Lyka Labs Limited has declared lack lustre (Consolidated) results for the quarter ending Dec,2010. These are compared with the previous qtr ended sep,2009 and corresponding qtr ending Dec,2009 and also the 12 months ended Sep,2010.

Net Sales : is Rs.33 Cr – down by 18.67% from previous qtr ended Sep’10; and up by 14.38% from corresponding qtr ended Dec,2009; and down by 5.1% on annualized basis (q1 x 4) from year ended Sep,2010.

Total Expenditure : is Rs.30 Cr – down by 19.84% from Q/e Sep’10; up by 16.85% from Q/ E Dec.2009 and down by 5.07% on annualized basis from Y/e Sep,2010.

Profit from Operations : is Rs.3.60 Cr; down by 21.56% from Q/e Sep,2010; up by 5.56% from Q/e Dec,2009; and down by 26.64% from Y/e Sep,2010 on annualized basis.

Profit before tax : is Rs.13.26 Cr; down by 86.56% from q/e Sep,2010; down by 69.31% from Q/e Dec,2009; and down by 80.13 from y/e Sep,2010 on annualized basis.

Consolidated Net Profit is : Rs.13.26 Cr – down by 90.44% from Q/e Sep,2010; down by 69.31% from Q/e Dec,2009; and down by 80.58% from y/e Sep,2010 (on annualized basis).

Basic EPS(in Rs.) is Rs.0.06 – against Rs.0.64 in Q/e Sep,2010; Rs.0.2 in Q/e Dec.2009; and Rs.1.27 for whole Y/e Sep,2010.

Thus, the consolidated results for Q1 ended Dec,2010 are totally lack lustre.

RESULTS TABLE :

LYKALABS - CONSOL	OCT10-DEC10	JUL10-SEP10	OCT09-DEC09	1009-0910
Net Sales	3300.74	4058.29	2885.71	13912.32
Net Sales	3300.74	-18.67	14.38	-5.1
Other Oprtg Income	89.75	181.4	48.79	820.15
Incr/Decr in SIT / WIP	97.68	201.28	-170.78	-183.12
Raw Materials	1009.83	1402.7	1196.8	5215.5
Traded goods	934.95	1040.5	566.53	3511.22
Employees Cost	347.98	283.87	279.88	1176.9
Depreciation	115.89	134.91	151.25	568.56
Other Expenditure	524.05	717.33	569.68	2480.01
Total Expenditure	3030.38	3780.59	2593.36	12769.07
Total Expenditure	3030.38	-19.84	16.85	-5.07
Profit from Operations	360.11	459.1	341.14	1963.4
Profit from Operations	360.11	-21.56	5.56	-26.64
Other Income	53.78	72.33	90.5	161.28
Interest	400.63	439.23	388.43	1719.57
Exceptional items	-	-6.49	-	138.24
Profit before tax	13.26	98.69	43.21	266.87
Profit before tax	13.26	-86.56	-69.31	-80.13
Tax Expense	-	-40	-	-6.26
Net Profit after tax	13.26	138.69	43.21	273.13
Net Profit	13.26	138.69	43.21	273.13
Consolidated Net Profit	13.26	138.69	43.21	273.13
Consolidated Net Profit	13.26	-90.44	-69.31	-80.58
Face Value (in Rs.)	10	10	10	10
Paid-up Equity	2158	2158	2158	2158
Reserves	-	-	-	7965.54
Basic EPS(in Rs.)	0.06	0.64	0.2	1.27
Public Holding (%)	76.7	76.7	76.7	76.7

ANNOUNCEMENTS

TO THE NSE

28-03-2011        the Board has fixed the date of Annual General Meeting as on April 29, 2011 and the Share Transfers Books and Registrar of Members will remain closed for a period of 5 days from April 25, 2011 to April 29, 2011 (both days inclusive) for the purpose of Annual General Meeting.

18-10-2010        The Company's factory at Ankleshwar has achieved record production for the month of September, 2010.

30-09-2010        The Company has been conferred 'Silver Patent Award' by the Department of Pharmaceuticals, Ministry of Chemical & Fertilizers, Government of India and Pharmaceutical Export Promotion Council for the year 2009-10 in recognition of commendable contribution in Formulation Patents Category.

14-08-2010        "A part of the Plant at Tarapur is undergoing upgradation from 1st August, 2010".

27-05-2009        "Our Bulk Drug Plant at Ankleshwar which was closed for the purpose of upgradation has been restarted".

13-05-2009        "Lyka BDR International Ltd has become a subsidiary of the Company."

*   *   *    E   N   D   *   *   *